A study in the latest issue of the Alimentary Pharmacology & Therapeutics prospectively examines the prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease.
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment, reports the most recent issue of the Alimentary Pharmacology & Therapeutics.
The latest issue of the Alimentary Pharmacology & Therapeutics investigates race-specific effects of alcohol and tobacco on the risk of esophageal squamous cell carcinoma.
November's issue of the Clinical Gastroenterology & Hepatology reports that central adiposity is associated with an increased risk of esophageal inflammation, metaplasia, and adenocarcinoma.
This week's issue of the British Medical Journal reports a prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic.
The latest issue of the Alimentary Pharmacology & Therapeutics investigates the use of an online tool developed by the RAND/UCLA appropriateness method for the management of iron deficiency in IBD.
The latest issue of the Alimentary Pharmacology & Therapeutics identifies factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .